Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor α-induced apoptosis, and inhibits tumor growth

被引:1
|
作者
Suh, KS [1 ]
Mutoh, M [1 ]
Gerdes, M [1 ]
Crutchley, JM [1 ]
Mutoh, T [1 ]
Edwards, LE [1 ]
Dumont, RA [1 ]
Sodha, P [1 ]
Cheng, C [1 ]
Glick, A [1 ]
Yuspa, SH [1 ]
机构
[1] NCI, Cellular Carcinogenesis & Tumor Promot Lab, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
mtCLIC/CLIC4 is a p53 and tumor necrosis factor alpha (TNFalpha) regulated intracellular chloride channel protein that localizes to cytoplasm and organelles and induces apoptosis when overexpressed in several cell types of mouse and human origin. CLIC4 is elevated during TNFalpha-induced apoptosis in human osteosarcoma cell lines. In contrast, inhibition of NFkappaB results in an increase in TNFalpha-mediated apoptosis with a decrease in CLIC4 protein levels. Cell lines expressing an inducible CLIC4-antisense construct that also reduces the expression of several other chloride intracellular channel (CLIC) family proteins were established in the human osteosarcoma lines SaOS and U2OS cells and a malignant derivative of the mouse squamous papilloma line SP1 Reduction of CLIC family proteins by antisense expression caused apoptosis in these cells. Moreover, CLIC4-antisense induction increased TNFa-mediated apoptosis in both the SaOS and U2OS derivative cell lines without altering TNFalpha-induced NFkappaB activity. Reducing CLIC proteins in tumor grafts of SPI cells expressing a tetracycline-regulated CLIC4-antisense substantially inhibited tumor growth and induced tumor apoptosis. Administration of TNFalpha. i.p. modestly enhanced the antitumor effect of CLIC reduction in vivo. These results suggest that CLIC proteins could serve as drug targets for cancer therapy, and reduction of CLIC proteins could enhance the activity of other anticancer drugs.
引用
收藏
页码:562 / 571
页数:10
相关论文
共 50 条
  • [1] Nerve growth factor inhibits apoptosis induced by tumor necrosis factor in PC12 cells
    Haviv, R
    Stein, R
    JOURNAL OF NEUROSCIENCE RESEARCH, 1999, 55 (03) : 269 - 277
  • [3] A new member of the tumor necrosis factor nerve growth factor receptor family inhibits T cell receptor-induced apoptosis
    Nocentini, G
    Giunchi, L
    Ronchetti, S
    Krausz, LT
    Bartoli, A
    Moraca, R
    Migliorati, G
    Riccardi, C
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) : 6216 - 6221
  • [4] TUNICAMYCIN POTENTLY INHIBITS TUMOR NECROSIS FACTOR-INDUCED HEPATOCYTE APOPTOSIS
    LEIST, M
    WENDEL, A
    EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION, 1995, 292 (02): : 201 - 204
  • [5] TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis
    Chicheportiche, Y
    Bourdon, PR
    Xu, HD
    Hsu, YM
    Scott, H
    Hession, C
    Garcia, I
    Browning, JL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) : 32401 - 32410
  • [6] Potentiation of tumor necrosis factor induced apoptosis by onconase
    Deptala, A
    Halicka, HD
    Ardelt, B
    Ardelt, W
    Mikulski, SM
    Shogen, K
    Darzynkiewicz, Z
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (01) : 11 - 16
  • [7] Linear ubiquitin chain induces apoptosis and inhibits tumor growth
    Qin, Zhoushuai
    Jiang, Wandong
    Wang, Guifen
    Sun, Ying
    Xiao, Wei
    APOPTOSIS, 2018, 23 (01) : 16 - 26
  • [8] Linear ubiquitin chain induces apoptosis and inhibits tumor growth
    Zhoushuai Qin
    Wandong Jiang
    Guifen Wang
    Ying Sun
    Wei Xiao
    Apoptosis, 2018, 23 : 16 - 26
  • [9] Tumor necrosis factor: An apoptosis JuNKie?
    Varfolomeev, EE
    Ashkenazi, A
    CELL, 2004, 116 (04) : 491 - 497
  • [10] Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand
    Reddy, RM
    Tsai, WS
    Ziauddin, MF
    Zuo, JT
    Cole, GW
    Maxhimer, JB
    Fang, BL
    Schrump, DS
    Nguyen, DM
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 128 (06): : 883 - 891